ERBB2 and urinary bladder cancer: Despite the significance of HER2 amplification/overexpression as a therapeutic target in various tumor types such as breast cancer, gastric cancer and bladder cancer, HER2's importance in ICC has received limited attention due to its infrequent genomic alterations.